Abstract
Current intensive chemotherapeutic regimens for the treatment of acute nonlymphocytic leukemia (ANLL) result in a substantial proportion of patients who enter prolonged first remissions and who may ultimately be cured of their leukemia (1–3). However, patients who experience hematologic relapses of ANLL have an extremely poor prognosis and a minimal chance for leukemia-free survival. Allogeneic bone marrow transplantation (BMT) in such patients provides an opportunity for cure, although the risks of graft-versus-host disease (GVHD) and opportunistic infections, notably viral interstitial pneumonitis, account for most of the mortality after allogeneic BMT (4–7). Furthermore, 60–75% of patients who are otherwise suitable allogeneic BMT candidates lack related MHC-matched donors, and allogeneic BMT is generally not feasible in patients over 40 years of age because of the high mortality associated with transplant-related complications (7–9).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Vaughan WP, Karp JE, Burke PJ (1984): Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia. Blood 64: 975–980.
Weinstein HJ, Mayer RJ, Rosenthal DS, et al. (1983): Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62: 315–319.
Wolff SN, Marion J, Stein RS, et al. (1984): High-dose (HD) cytosine arabinoside (Ara-C) and daunorubicin (D) for acute non-lymphocytic leukemia (ANLL) in first remission. Proc ASCO 3: 193 (Abstract).
O’Reilly RJ (1983): Allogeneic bone marrow transplantation: Current status and future directions. Blood 62: 941–964.
Meyers JD, Flournoy N, Thomas ED (1982): Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years’ experience. J Inf Dis 4: 1119–1132.
Santos GW (1984): Bone marrow transplantation in leukemia: Current status. Cancer 54: 2732–2740.
Santos GW, Tutschka PJ, Brookmeyer R, et al. (1983): Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309: 1347–1353.
Thomas ED, Buckner CD, Clift RA, et al. (1979): Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597–599.
Thomas ED, Clift RA, Buckner CD (1982): Marrow transplantation for patients with acute nonlymphoblastic leukemia who achieve a first remission. Cancer Treat Rep 66: 1463–1466.
Sharkis SJ, Santos GW, Colvin OM (1980): Elimination of acute myelogenous leukemia cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. Blood 55: 521–523.
Takamizawa A, Matsumoto S, Iwata T, et al. (1973): Studies on cyclophosphamide metabolites and their related compounds. II. Preparation of an active species of cyclophosphamide and some related compounds. J Am Chem Soc 95: 985–986.
Kaizer H, Stuart RK, Brookmeyer R, et al. (1985): Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 65: 1504–1510.
Thomas ED, Storb R (1970): Technique for human marrow grafting. Blood 36: 507–515.
Santos GW, Bias WB, Beschorner WE, et al. (1983): Allogeneic and syngeneic marrow transplantation for acute lymphocytic leukemia (ALL) in remission — Baltimore experience. Exp Hematol 11 (Suppl 14): 132 (Abstract).
Hickman RO, Buckner CD, Clift RA, et al. (1979): A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148: 871–875.
Saral R, Burns WH, Laskin OL, et al. (1981): Acyclovir prophylaxis of herpes simplex virus infections: A randomized double-blind controlled trial in bone marrow transplant recipients. N Engl J Med 305: 63–67.
Kaplan EM, Meier P (1958): Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.
Fefer A, Cheever MA, Greenberg PD, et al. (1983): Bone marrow transplantation (BMT) with identical twins: Improved results with BMT in complete remission (CR). Proc ASCO 2: 182 (Abstract).
Weiden PL, Flournoy N, Thomas ED, et al. (1979): Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300: 1068–1073.
Weiden PL, Sullivan KM, Flournoy N, et al. (1981): Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304: 1529–1532.
Dicke KA, Zander A, Spitzer G, et al. (1978): Autologous bone marrow transplantation in relapsed adult leukemia. Lancet 1: 1514–1517.
Feeney M, Knapp RC, Greenberger JS, et al. (1981): Elimination of leukemic cells from rat bone marrow using antibody and complement. Cancer Res 41: 3331–3335.
Bast RC Jr, Ritz J, Lipton JM, et al. (1983): Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res 43: 1389–1394.
Uckun FM, Ramakrishnan S, Houston LL (1985): Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. J Immunol 134: 2010–2016.
Ramsay N, LeBien T, Nesbit M, et al. (1985): Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood 66: 508–513.
Anderson KC, Sallan S, Takvorian T, et al. (1985): Monoclonal antibody (MA) purged autologous bone marrow transplantation (ABMT) for relapsed non-T acute lymphoblastic leukemia (ALL). Int J Cell Cloning 3: 239–240 (Abstract).
Gorin NC, Douay L, Laporte JP, et al. (1985): Autologous bone marrow transplantation using marrow incubated with ASTA-Z-7557 in adult acute leukemia. Int J Cell Cloning 3: 249–250 (Abstract).
Herve P, Cahn JY, Flesch M, et al. (1985): Autologous bone marrow transplantation (ABMT) for acute leukemia in remission. Int J Cell Cloning 3: 242–243 (Abstract).
Rowley SD, Colvin OM, Stuart RK (1985): Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Exp Hematol 13: 295–297.
Burnett AK, Tansey P, Alcorn M, et al. (1984): Autologous bone marrow transplantation in first remission of acute myelogenous leukemia. Exp Hematol 12 (Suppl 15): 126–127.
Burnett AK, Tansey P, Watkins R, et al. (1984): Transplantation of unpurged autologous bone-marrow in acute myeloid leukemia in first remission. Lancet 2: 1068–1070.
Gorin NC (1984): Autologous bone marrow transplantation for acute leukemia in Europe. Exp Hematol 12 (Suppl 15): 123–125.
Laporte JP, Gorin NC, Douay L, et al. (1984): Autologous bone marrow transplantation (ABMT) with marrow purged by ASTA Z-7557, as consolidation therapy for acute leukemias in first remission. Exp Hematol 12 (Suppl 15): 132.
Nerve P, Cahn JY, Plouvier E, et al. (1984): Autologous bone marrow transplantation in acute leukemia using marrow cells chemopurified with a cyclophosphamide derivative (ASTA Z 7557): Clinical results. Exp Hematol 12 (Suppl 15): 133–134.
Appelbaum FR, Meyers JD, Fefer A, et al. (1982): Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. Transplantation 33: 265–268.
Lowenberg B, Abels J, van Bekkum DW, et al. (1984): Transplantation of non-purified autologous bone marrow in patients with AML in first remission. Cancer 54: 2840–2843.
Stewart P, Buckner CD, Bensinger W, et al. (1985): Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. Exp Hematol 13: 267–272.
Champlin RE, Ho WG, Gale RP, et al. (1985): Treatment of acute myelogenous leukemia: A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Int Med 102: 285–291.
Appelbaum FR, Dahlberg S, Thomas ED, et al. (1984): Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia: A prospective comparison. Ann Int Med 101: 581–588.
Dicke KA, Jagannath S, Vellekoop L, et al. (1985): Results of autologous bone marrow transplantation in second and subsequent remissions in acute leukemia. Int J Cell Cloning 3: 240 (Abstract).
Bortin MM, Buckner CD (1983): Major complications of marrow harvesting for transplantation. Exp Hematol 11: 916–921.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Yeager, A.M. et al. (1986). Autologous Bone Marrow Transplantation in Acute Nonlymphocytic Leukemia a Study of Ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide. In: Hagenbeek, A., Löwenberg, B. (eds) Minimal Residual Disease in Acute Leukemia 1986. Developments in Oncology, vol 45. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4273-8_22
Download citation
DOI: https://doi.org/10.1007/978-94-009-4273-8_22
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8398-0
Online ISBN: 978-94-009-4273-8
eBook Packages: Springer Book Archive